Aquestive Therapeutics, Inc. (NASDAQ:AQST) Given Consensus Recommendation of “Buy” by Brokerages
Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Free Report) has earned a consensus recommendation of “Buy” from the eight ratings firms that are covering the firm, Marketbeat.com reports. Seven research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target […]
Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Free Report) has earned a consensus recommendation of “Buy” from the eight ratings firms that are covering the firm, Marketbeat.com reports. Seven research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target […]
